Xtant Medical Inc. (XTNT)
| Bid | 0.7 |
| Market Cap | 102.65M |
| Revenue (ttm) | 122.3M |
| Net Income (ttm) | -11.99M |
| EPS (ttm) | -0.09 |
| PE Ratio (ttm) | -8.19 |
| Forward PE | -71 |
| Analyst | Strong Buy |
| Ask | 0.77 |
| Volume | 87,860 |
| Avg. Volume (20D) | 216,073 |
| Open | 0.71 |
| Previous Close | 0.73 |
| Day's Range | 0.69 - 0.74 |
| 52-Week Range | 0.33 - 0.83 |
| Beta | -0.13 |
About XTNT
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for XTNT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
2 months ago · seekingalpha.com
Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call TranscriptXtant Medical Holdings, Inc. (NYSE:XTNT ) Q4 2024 Results Conference Call March 6, 2025 4:30 PM ET Company Participants Brett Maas - Hayden IR Sean Browne - President & Chief Executive Officer Scott N...
2 months ago · accessnewswire.com
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial ResultsFull Year 2024 Revenue Growth of 28% Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 / Xtant Medical Holdings, I...
2 months ago · accessnewswire.com
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...